PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.

Robert T WechslerJames WhelessMuhammad ZafarGraham R HuesmannMarcelo LancmanEric SegalMichael ChezSami AboumatarAnna PattenAlejandro SalahManoj Malhotra

Published in: Epilepsia open (2022)

In this final analysis of >1700 patients with epilepsy receiving perampanel in routine clinical care, favorable retention and sustained efficacy were demonstrated for ≥12 months.

Keyphrases

healthcare
palliative care
quality improvement
pain management
affordable care act
cross sectional